Oxcarbazepine Tablet
Product Images NDC 72888-461

This text provides information about Oxcarbazeping tablets, each containing 150mg of the active ingredient. The storage instructions suggest keeping the tablets in a tight container at temperatures between 15°C-30°C (59°F-86°F). It emphasizes keeping medications out of reach of children and dispensing the medication guide to each patient. The manufacturing and distribution details are also included. For more details, refer to the package insert and Medication Guide available online provided by Advagen Pharma.*

This is information about Oxcarbazepine tablets, where each film-coated tablet contains 300 mg of Oxcarbazepine USP. The tablets should be stored at 25°C (77°F), with excursions permitted to 15°C-30°C (59°F-86°F). It is recommended to dispense in a tight container, and the usual dosage can be found in the package insert. Keep the medication out of reach of children. The packaging contains a medication guide and package insert available online. The tablets are for prescription use only and should be accompanied by the medication guide when dispensed to each patient. The drug is distributed by Advagen Pharma Ltd., based in East Windsor, NJ, USA, and manufactured by Rubicon Research Ltd., located in Thane 421506, India.*

Each film-coated tablet of Oxcarbazepine USP contains 600 mg. The tablets should be stored at 25°C (77°F) with excursions permitted to 15°C-30°C (59°F-86°F). Dispense in a tight container. The usual dosage information is available in the package insert. Keep the medication out of the reach of children. Make the Medication Guide and Package Insert available to each patient. Visit https://www.advagenpharma.com/medguide_pil/oxcarbazepinetabletsusp for more information. NDC 72888-461-01. This medication is for prescription use only. Distributed by Advagen Pharma Ltd., East Windsor, NJ 08520, USA. Manufactured by Rubicon Research Ltd., Thane 421506, India. Manufacturing License No: KD-682. Rev.00, 11/24.*